2-Methoxystypandrone was able to block STAT3 and NF-κB pathways by covalently interacting the upstream kinase JAK2 and IKK, inhibited cell growth/survival, and eventually induced apoptosis in human cancer cells [15, 37]. The gene discussed is JAK2; the disease is cancer.